COMMENTARY - Covid-19 preparedness and response: experiences of the Nigerian Institute for Medical Research

Rosemary R. Audu(1), Chika K. Onwuamah(2), Azuka P. Okwuraiwe(3), Olufemi S. Amoo(4), Ayorinde B. James(5), Joseph O. Shaibu(6), Fehintola A. Ige(7), Aigbe G. Ohihoin(8), Agatha N. David(9), Gideon Liboro(10), Ebenezer O. Odewale(11), Judith Sokei(12), Chika L. Okoli(13), Dominic A. Achanya(14), Adesegun A. Adesesan(15), Bosede O. Amuda(16), Ponmak D. Jamda(17), Rahaman Ahmed(18), Muinah A. Fowora(19), Olugbenga O. Aina(20), Oliver C. Ezechi(21), Richard A. Adegbola(22), Babatunde L. Salako(23),


(1) Nigerian Institute of Medical Research (NIMR)
(2) Nigerian Institute of Medical Research (NIMR)
(3) Nigerian Institute of Medical Research (NIMR)
(4) Nigerian Institute of Medical Research (NIMR)
(5) Nigerian Institute of Medical Research (NIMR)
(6) Nigerian Institute of Medical Research (NIMR)
(7) Nigerian Institute of Medical Research (NIMR)
(8) Nigerian Institute of Medical Research (NIMR)
(9) Nigerian Institute of Medical Research (NIMR)
(10) Nigerian Institute of Medical Research (NIMR)
(11) Nigerian Institute of Medical Research (NIMR)
(12) Nigerian Institute of Medical Research (NIMR)
(13) Nigerian Institute of Medical Research (NIMR)
(14) Nigerian Institute of Medical Research (NIMR)
(15) Nigerian Institute of Medical Research (NIMR)
(16) Nigerian Institute of Medical Research (NIMR)
(17) Nigerian Institute of Medical Research (NIMR) & Federal College of Veterinary and Medical Laboratory Technology.
(18) & University of Lagos, Akoka, Lagos & Nigerian Institute of Medical Research (NIMR)
(19) Nigerian Institute of Medical Research (NIMR)
(20) Nigerian Institute of Medical Research (NIMR)
(21) Nigerian Institute of Medical Research (NIMR)
(22) Nigerian Institute of Medical Research (NIMR)
(23) Nigerian Institute of Medical Research (NIMR) & University of Ibadan
Corresponding Author

Abstract


The global community is facing a health crisis caused by coronavirus disease 2019 (COVID-19). The coronavirus pandemic is severely disrupting the global economy. Countries are battling to slow the spread of the virus by testing, employing contact tracing, restricting travel, quarantining citizens, and encouraging use of face mask, hand hygiene and social distancing measures. The lockdown imposed in many countries including Nigeria has resulted in increased cost and shortages of reagents and supplies worldwide. Due to the highly contagious nature of the disease, rapid rate of spread, and lack of an effective therapy, it became necessary for nations of the world to mount an efficient response mechanism to curb the spread of the pandemic. The Nigerian Institute of Medical Research (NIMR) has responded actively to the current pandemic with some innovations with respect to sample collection systems, molecular diagnostics, kit development and validation. Due to the highly infectious nature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the causative agent of COVID-19, the institute also invested in the production of infection control tools. The extent of response by the institute would not have been possible but for collaboration and partnership with well-meaning organizations and stakeholders. National, State and public cooperation are very essential for effective response to any pandemic. The response of NIMR to the pandemic is herein discussed. Lessons learned and recommendations made are also shared to help institutions interested in combating this and future pandemics of similar nature.


Keywords


Pandemics, preparedness, COVID-19, response

References


ABC/Reuters (29 January 2008). "Black death 'discriminated' between victims (ABC News in Science)". Australian Broadcasting Corporation. Archived from the original on 20 December 2016. Retrieved 3 November 2008.

"Black Death's Gene Code Cracked". Wired. 3 October 2001. Archived from the original on 26 April 2015. Retrieved 12 February 2015.

"Health: De-coding the Black Death". BBC. 3 October 2001. Archived from the original on 7 July 2017. Retrieved 3 November 2008.

J Horgan. The Plague at Athens, 430-427 BCE. Ancient History Encyclopedia published on 24 August 2016.https://www.ancient.eu/article/939/the-plague-at-athens-430-427-bce/

Past pandemics that ravaged Europe. BBC News, 7 November. 2005

Quotes from book "Plague and the End of Antiquity" Archived 16 July 2011 at the Way back Machine Lester K. Little, ed., Plague and the End of Antiquity: The Pandemic of 541–750, Cambridge, 2006. ISBN 0-521-84639-0

"Plague, Plague Information, Black Death Facts, News, Photos". National Geographic. Retrieved 3 November 2008.

Sir Macfarlane Burnet and David O. White, Natural History of Infectious Disease (4th ed., Cambridge, 1972), 202; Edwin O. Jordan, Epidemic Influenza: A Survey (Chicago, 1927), 229; Alfred W. Crosby, Epidemic and Peace, IQI8 (Westport, Conn., 1976), 207, 311. For the epidemiology of the disease, see W. I. B. Beveridge, Influenza: The Last Great Plague: An Unfinished Story of Discovery (New York, 1977); and Peter Palese and James F. Young, 'Variation of influenza A, B, and C viruses', Science, ccxv (19 Mar. 1982), 1468-74.

Don C. Ohadike. Diffusion and Physiological Responses to the Influenza Pandemic of 1918-19 in Nigeria. Sm. Sci. Med. Vol. 32, No. 12, pp. 1393-1399, 1991.

CDC, Disease of the Week: SARS (10 Years After). https://www.cdc.gov/dotw/sars/index.html

Worldometer. Countries where COVID-19 has spread. https://www.worldometers.info/coronavirus/countries-where-coronavirus-has-spread/

COVID-19 pandemic: Humanity needs leadership and solidarity to defeat the coronavirus. United Nations Development Programme: https://www.undp.org/content/undp/en/home/coronavirus.html

First African SARS-CoV-2 genome sequence from Nigerian COVID-19 case. Novel 2019 coronavirus Genome Reports.http://virological.org/t/first-african-sars-cov-2-genome-sequence-from-nigerian-covid-19-case/421

Jason Beaubien - March 26, 2020- How South Korea reined in the outbreak without shutting everything down. Swiss Med Wkly. 2020 Mar 19; 150: w20225.doi: 10.4414/smw.2020.20225. eCollection 2020 Mar 9.

WHO Laboratory biosafety guidance related to coronavirus disease (COVID-19). Interim guidance. 13 May 2020

Bedford J, Farrar J, Ihekweazu C, Kang G, Koopmans M, Nkengasong J. Review. A new twenty-first century science for effective response. Nature 2019; 575:130-136.

Wang J, Liu F, Tan JBX, Harbarth S, Pittet D, & Zingg W. Implementation of infection prevention and control in acute care hospitals in Mainland China e a systematic review. Antimicrob Resist Infect Control 2019; 8:32.

Chang D, Xu H, Rebaza A, Sharma L, & Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020 Feb 13 [Epub ahead of print].

Wanga J, Zhoub M & Liua F. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China, Journal of Hospital Infection, https://doi.org/10.1016/j.jhin.2020.03.002

CY Park, Global Shortage of Personal Protective Equipment amid COVID-19: Supply Chains, Bottlenecks, and Policy Implications. No 130, April ‎2020. https://www.adb.org/sites/default/files/publication/579121/ppe-covid-19-supply-chains-bottlenecks-policy.pdf


Full Text: PDF

Article Metrics

Abstract View : 410 times
PDF Download : 97 times

DOI: 10.57046/IBEH6230

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Proceedings of the Nigerian Academy of Science

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.